Arkolith/Insider Trading/XFOR/Form 4/A

Baldry Mark

Chief Commercial OfficerX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4/A · filed Jun 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 16, 2025Grant(A)1K$2.48$3K25K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001628280-25-029113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML